These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
MiniMed Group sold more stuff than people expected this quarter, which made investors happy and caused experts to say the stock might be worth more money. When a company does better than expected, it's a sign the business is doing well—but remember, prices can always change.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.